| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 781.90M | 700.00M | 588.50M | 745.50M | 795.10M |
| Gross Profit | 631.20M | 594.60M | 295.50M | 627.10M | 663.90M |
| EBITDA | 229.80M | 221.40M | 234.20M | 231.20M | 286.10M |
| Net Income | 153.50M | 150.10M | 163.90M | 163.80M | 205.30M |
Balance Sheet | |||||
| Total Assets | 14.88B | 12.21B | 11.12B | 10.81B | 11.68B |
| Cash, Cash Equivalents and Short-Term Investments | 462.00M | 11.79B | 378.50M | 10.34B | 11.18B |
| Total Debt | 104.30M | 86.60M | 94.70M | 102.70M | 109.40M |
| Total Liabilities | 14.17B | 11.84B | 10.75B | 10.46B | 11.34B |
| Stockholders Equity | 702.40M | 373.40M | 367.40M | 349.80M | 341.50M |
Cash Flow | |||||
| Free Cash Flow | 170.80M | 314.00M | 169.30M | 73.40M | 653.20M |
| Operating Cash Flow | 177.90M | 318.40M | 171.80M | 74.60M | 654.60M |
| Investing Cash Flow | 4.00M | -7.80M | -4.40M | 2.40M | -393.10M |
| Financing Cash Flow | -165.00M | -165.40M | -163.80M | -164.30M | -145.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | £4.17B | 10.45 | 8.13% | 7.21% | -1.72% | 63.64% | |
76 Outperform | £9.07B | 16.93 | 12.35% | 5.37% | 12.45% | 28.89% | |
74 Outperform | £2.52B | 21.62 | 8.35% | 3.40% | 71.85% | ― | |
72 Outperform | £4.20B | 12.76 | 41.35% | 5.93% | 9.80% | 1.81% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | £1.64B | 13.20 | 8.33% | 4.91% | 2.02% | 69.06% | |
52 Neutral | £7.89B | 25.83 | 9.49% | 7.09% | 52.52% | ― |